Anorectal Manometry of Patients With Constipation Predominant IBS

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

102 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-07-01

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of The study is to compare between the anorectal manometric profile of patients with functional constipation and patients with constipation predominant irritabe bowel syndrome

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Expression of the Ionotropic Glutamate Receptors in Colon of IBS

NCT02512146

Irritable Bowel Syndrome

UNKNOWN

IBS-C Questionnaire Study

NCT04968652

Irritable Bowel Syndrome With Constipation Functional Constipation

COMPLETED

Assessment of Psychological Symptoms and Health Related Quality of Life in Patients With Irritable Bowel Syndrome

NCT05480059

IBS - Irritable Bowel Syndrome

UNKNOWN

Fecal Microbiota Transplantation to Relieve Symptoms of Irritable Bowel Syndrome With Constipation

NCT05803993

Irritable Bowel Syndrome

RECRUITING NA

Factors Affecting Dissatisfaction to Treatments in Patients With Chronic Constipation and IBS With Constipation

NCT02813616

Constipation Irritable Bowel Syndrome

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Chronic constipation (CC) is a common medical problem throughout the world \[1-3\] The global prevalence of CC in the community varies from 11% to 18% \[4\].

In patients presenting to tertiary care facilities, specific pathophysiological abnormalities like defecatory disorder and slow colonic transit contribute to CC.

CC has a significant burden on the utilization of healthcare resources, including the cost of inpatient and outpatient care, laboratory tests, and diagnostic procedures \[5, 6\].

CC is characterized by difficulty in passing stools or a low frequency of bowel movements, often accompanied by straining during defecation or a feeling of incomplete evacuation \[7, 8\].

For western population, CC is defined by Bristol stool form (BSF) I-II, while in Indian patients, addition of type III Bristol stool form increases diagnostic sensitivity \[2\]. In the ROME IV criteria, it has been suggested that all patients with CC without evidence of structural or metabolic abnormalities to explain symptoms should be considered under the umbrella of functional constipation (FC) \[8\].

FC is defined as the presence of two or more of the followings during the previous 3 months:

1. Defecatory straining (\> 25% of bowel movements)
2. Hard or lumpy stools (\> 25% of bowel movements)
3. Feeling of incomplete evacuation (\> 25% of bowel movements)
4. Defecatory obstruction (\> 25% of bowel movements)
5. Manual maneuvers to facilitate defecation (\> 25% of bowel movements)
6. Fewer than three spontaneous complete bowel movements per week. Symptoms must be present for at least 6 months before the diagnosis, and diarrhea must not be present except after using a laxative \[8\].

Patients with FC should not meet irritable bowel syndrome (IBS) criteria, although bloating may be present. In contrast, patients with irritable bowel syndrome with constipation (IBS-C) have abdominal pain as the predominant symptom along with Bristol stool form types 1 or 2 more than 25% of the times. \[8\].

Among patients presenting with CC, Indian studies have reported FC to be commoner than IBS-C \[9, 10-12\].

High-resolution (HR-) anorectal manometry has significant diagnostic value in the assessment of anorectal disorders \[13\] This study aimed to compare the clinical and anorectal manometry profile of patients with FC and constipation-predominant irritable bowel syndrome

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Constipation-predominant Irritable Bowel Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age between 18- 60 years old .
2. Patients fulfill ROME IV criteria of chronic constipation.

Exclusion Criteria

* Patient with secondary causes of constipation :-

1. Thyroid disease
2. Acute or chronic kidney disease
3. Acute or Chronic Liver Disease.
4. Malignancy 5 -Medication 6 -Uncontrolled diabetes mellitus 7 -Inflammatory bowel diseases

Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No